Abstract
Immune-cell type, density, and location in colorectal tumours predicts clinical outcome, say Jérôme Galon (French National Institute of Health and Medical Research, Paris, France) and colleagues. The researchers used gene-expression profiling and in-situ immunohistochemical staining to characterise tumour-infiltrating immune cells in patients with colorectal cancer (Science 2006; 313: 1960–64).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
